David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BERY
276
DELISTED
Berry Global Group, Inc.
BERY
| $45M | 0.08% |
1,356,232
-392,737
| -22% | -$11.4M |
|
277
PUT
Pfizer
PFE
$160B
| $45M | 0.08% |
1,599,656
+84,320
| +6% | +$2.41M |
|
278
Analog Devices
ADI
$182B
| $44.9M | 0.08% |
759,387
+427,072
| +129% | +$22.8M |
|
|
SAVE
279
DELISTED
Spirit Airlines, Inc.
SAVE
| $44.9M | 0.08% |
936,160
-114,640
| -11% | -$5.13M |
|
280
PUT
Goldman Sachs
GS
$303B
| $44.8M | 0.08% |
285,300
+58,600
| +26% | +$9.06M |
|
281
CALL
SLB Ltd
SLB
$79.9B
| $44.6M | 0.08% |
604,800
+194,200
| +47% | +$13.7M |
|
282
CALL
Caterpillar
CAT
$381B
| $44.6M | 0.08% |
582,200
+130,700
| +29% | +$8.77M |
|
283
US Bancorp
USB
$96.7B
| $44.5M | 0.08% |
1,096,636
-756,671
| -41% | -$30.2M |
|
284
Pilgrim's Pride
PPC
$7.68B
| $44.4M | 0.08% |
1,748,131
+231,097
| +15% | +$5.36M |
|
285
Valero Energy
VLO
$100B
| $44.4M | 0.08% |
692,113
-1,122,251
| -62% | -$71.4M |
|
286
AXIS Capital
AXS
$7.2B
| $44.4M | 0.08% |
800,122
+409,527
| +105% | +$22.1M |
|
|
TWTR
287
PUT
DELISTED
Twitter, Inc.
TWTR
| $44.3M | 0.08% |
2,678,700
-323,500
| -11% | -$5.67M |
|
|
MDVN
288
DELISTED
MEDIVATION, INC.
MDVN
| $44.3M | 0.08% |
963,179
-118,769
| -11% | -$4.31M |
|
289
Thermo Fisher Scientific
TMO
$233B
| $44.3M | 0.08% |
312,542
-128,680
| -29% | -$17.2M |
|
|
ITC
290
DELISTED
ITC HOLDINGS CORP
ITC
| $44.1M | 0.08% |
1,011,239
+408,098
| +68% | +$16.6M |
|
291
CALL
Home Depot
HD
$335B
| $44M | 0.08% |
330,100
+52,200
| +19% | +$6.51M |
|
292
PUT
JPMorgan Chase
JPM
$935B
| $43.9M | 0.08% |
741,800
-606,300
| -45% | -$35.4M |
|
293
United Therapeutics
UTHR
$22B
| $43.9M | 0.08% |
393,960
-60,251
| -13% | -$7.62M |
|
294
Magna International
MGA
$19.5B
| $43.9M | 0.08% |
1,020,939
+99,118
| +11% | +$3.69M |
|
295
Infosys
INFY
$48.4B
| $43.7M | 0.08% |
4,592,794
+3,992,348
| +665% | +$34.8M |
|
|
AVB
296
DELISTED
AvalonBay Communities
AVB
| $43.3M | 0.08% |
227,659
+73,383
| +48% | +$13M |
|
297
Hubbell
HUBB
$24.8B
| $43.2M | 0.08% |
407,484
+3,025
| +0.7% | +$289K |
|
298
Regeneron Pharmaceuticals
REGN
$85.9B
| $43.1M | 0.08% |
119,569
-2,104
| -2% | -$867K |
|
299
Radian Group
RDN
$4.84B
| $42.9M | 0.08% |
3,462,188
+1,644,736
| +90% | +$18.6M |
|
300
FedEx
FDX
$76.9B
| $42.9M | 0.08% |
263,663
-631,380
| -71% | -$87.8M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.